Ton Adang, Ph.D. worked at several biotech companies and at Merck/MSD, Schering-Plough and Organon in research and development positions with increasing responsibilities. He held leadership positions in the lead discovery unit and in project management, developing a product through U.S. Food and Drug Administration approval and targeting new indications like breast cancer, osteoporosis as well as working with human vaccines, biosimilars and in immuno-oncology. He received a doctor of philosophy degree from the University of Leiden at the divisions of biopharmaceutical sciences and bio-organic chemistry.